Quantum Technology & Neurotechnology Innovation Networks: Quantum magnetic sensors for brain imaging
1. Connecting for Positive Change
KTN connects ideas, people and
communities to drive innovation that
changes lives.
2. www.ktn-uk.org
Bob Cockshott
Quantum Technology Innovation Network
Charlie Winkworth-Smith
Neurotechnology Innovation Network
Gabriela Juarez-Martinez
KTN Healthcare Team
Quantum Magnetic Sensors for Brain Imaging
12 November 2020 10:00 – 12:00
3. • 10:00 Welcome & housekeeping, Bob Cockshott & Charlie Winkworth-Smith
• 10:05 Quantum magnetic sensors, Prof Matt Brookes
• 10:30 SERF Magnetometry for MEG, Dr Carolyn O’Dwyer
• 10:55 Clinical challenges in MEG applications, Prof Stefano Seri
• 11:20 Panel Q&A
• 11:50 Closing remarks
Agenda
4. Delegates will be muted during the presentations
Please use the Q & A box to post questions for the Q & A session
Please only use the chat box for technical issues
Housekeeping
6. Major Challenges
1 in 4 people will suffer from a mental health disorder at some point in
their lifetime.
However little is known about the neural substrates that underlie serious
mental health conditions and there are often no effective treatments
In 2015, ~29,800,000 were suffering with Alzheimer’s disease
In an aging population, prevalence of dementia is growing markedly
Yet again little is known about the neural substrates that underlie
neurodegeneration, and treatments are lacking
We know relatively little of how the brain changes in order to
support cognition as we grow up, or how it declines in old
age
7. Major Challenges
Around 60 million people worldwide suffer from epilepsy, a severe neurological
disorder which results from abnormal electrical activity in the brain.
Epilepsy is extremely debilitating with patients suffering seizures; only 60% of
cases are well controlled with pharmacological intervention
Over 100,000 people in the UK are admitted to hospital per year with mild
traumatic brain injury (mTBI). >50% will develop post concussion symptoms but
there are no objective assessments for diagnosis
Around 1 in every 100 people suffers from schizophrenia – a
severe and debilitating mental health disorder which results in
impaired expression and perception of reality
Many of the ‘negative’ symptoms of schizophrenia are poorly
controlled by drugs leading to impaired quality of life
9. Brain Imaging
Brain imaging has proved a remarkably successfully
means to understand the brain and diagnose illnesses
e.g. Modern MRI scanners, particularly ultra high field,
offer structural scans with high resolution. The drive to
higher field offers even further advantages.
However…
• Most brain imaging techniques measure the
structure of the brain
• Often, in mental health disorders, brain structure is
normal and it is abnormal activity of neuronal
assemblies that underlies many
11. Basic Principle
( ) ( ) )(,Qˆ tt
T
BrWr =
( ) ( )
( ) ( )[ ]11
1
--
-
=
rLCrL
CrL
rW
T
T
Reconstruction of MEG data relies on mathematical projection of extra-cranial
magnetic fields into source space
( ) ( ) ( ) IrLrWQrW =ú
û
ù
ê
ë
é
÷
ø
ö
ç
è
æ T
ts ..ˆmin
2
e
MAGNETIC FIELDS INFERRED CURRENT
Possible to get images of current density change when a person undertakes a task
SOURCE
LOCALISATION
15. OPM-MEG development – 2015 – 2020
A new
generation of
quantum
sensors have
enabled
‘wearable’ brain
imaging
technology
On scalp MEG
simulations 2016
Single channel
recording 2017
First wearable
OPM array 2018
First paediatric
helmet 2019
First Gen II OPM
recordings 2019
50 channel whole
head system 2020
Conventional
MEG
First VR-MEG
recording 2019
First simultaneous
OPM/EEG 2019
18. Natural head movement
Experiment:
• 10 s bouncing ball
• 10 s rest bat on knee
• repeated 29 times
20 s
10 s
restping pong
Boto et al, Nature 2018
19. Paedriatic OPM-MEG – Measurements in children
-100
100
24 year old
10
70
Time (s)0 5
-100
5 year old
10
70
Time (s)0 5
100
-100
2 year old
10
70
Time (s)0 5
100
Images shown with written permission
Hill et al. Nature Coms, 2019
20. Next generation neuroscience
Traditional neuroimaging
employs paradigms that
typically comprise 2D visual
projection on a screen
It is hard to generate a fully
immersive environment in
which subjects can
experience “life like”
scenarios
The use of Virtual Reality stimulation with neuroimaging could revolutionise the
types of experiment that are possible
Roberts et al. NeuroImage 2019
21. Outperforming competitive technology
Concurrent EEG/OPM-MEG
Boto et al. NeuroImage, 2019
StationaryMovingMoving more
OPM-MEG EEGEEG ~10 times
more sensitive
to muscle
artifact than
MEG
EEG poor
spatial
resolution
EEG OPM-MEG
22. Outperforming competitive technology
• Play 5 chords on a
Ukulele
• Measure brain
activity as people
learn to play the
chords
• Look for changes
when subjects get
the chords
right/wrong
Poorly played chords Correctly played chords
23. Unprecedented potential
• Quantum sensors can get closer to the brain than conventional
cryogenic sensors, meaning higher sensitivity and better spatial
precision
• Flexibility of sensor placement allows a quantum enabled system to
adapt to any head shape. This means we can scan anyone - babies
and adults with optimal sensor placement.
• Wearability of the system means that the sensors move with the head
and so, assuming background fields are controlled, we can scan
people whilst they are moving.
• Conventional scanners are extremely expensive to buy and run. Even
at this early stage of development a quantum enabled system is <50%
of the cost of a conventional system.
25. Acknowledgements
Richard Bowtell
Peter Morris
Karen Mullinger
Elena Boto
Lauren Gascoyne
Lucrezia Liuzzi
James Leggett
Niall Holmes
Gillian Roberts
Ryan Hill
Zelekha Abid
Molly Rea
Izzy Gale
Mark Fromhold
Mike Packer
COLLEAGUES AND COLLABORATORS
Gareth Barnes
Tim Tierney
Leo Duque-Munoz
Eleanor Maguire
Sven Bestmann
Sofie Meyer
George O’Neill
Mark Woolrich
Rebeccah Slater
Caroline Hartley
Andrew Quinn
Margot Taylor
Ben Dunkley
Ben Hunt
Vishal Shah
James Osbourne
Paul Furlong
Klaus Kessler
Mike Hall
Nic Alexander
35. Optically Pumped Magnetometer for MEG:
Specifications
• Sensitive
• Compact & low standoff
• Scalable to arrays
• Low temperature
• Low cost
9
36. Why Use Atoms?
• Every atom of an isotope is exactly
the same
• Alkali atoms are hydrogen-like -
simple and predictable
• Easily manipulated using lasers
• Ultra-precise measurements
10
37. • Pump atomic ensemble & create
magnetisation
• Atoms precess about magnetic
field at Larmor frequency
• Precession imprinted on probe
beam
• ωLarmor = γB0
B0
ωLarmor
Optically Pumped Magnetometry
11
38. • Shielded or compensated room
creates a quiet environment for
sensor
• Sensor has a response at zero-
field
• Any signal arising shifts the Larmor
frequency
Zero-Field Magnetometry
12 Amplitude
Magnetic Field
0
39. • Shielded or compensated room
creates a quiet environment for
sensor
• Sensor has a response at zero-
field
• Any signal arising shifts the Larmor
frequency
Zero-Field Magnetometry
13 Amplitude
Magnetic Field
0
47. Challenges
• Heating: ~110℃ at cell, ~30℃ at scalp
• Laser supply chain - tunable and stable packages
• Optimisation of vapour cell fill pressure and geometry
• Two-cell operation - gradiometry
21
48. Progress & Outlook
• Lab experiment complete
• Optimisation and calibration ongoing
• Sensitivity estimate - compare to
current available sensors
• Portable component testing in lab
environment
22
-1000 -500 0 500 1000
Magnetic Field (nT)
0.1
0.11
0.12
0.13
0.14
0.15
0.16
SignalAmplitude(V)
49. SERF Magnetometry Team
Erling Riis
Paul Griffin
Stuart Ingleby
Terry Dyer
Iain Chalmers
Rachel Dawson
Edward Irwin
Marcin Mrozowski
23
50. Clinical challenges in MEG
applications
Stefano Seri MD, PhD, FRCP
Wellcome Laboratory for MEG Studies, Aston Univesity
Birmingham Women’s and Children’s NHS FT CESS Programme
51. The puzzling dichotomy
• Continuous growth in the number of publications: in the first 9
months of 2020 alone:
• Epilepsy 80 studies
• Schizophrenia 20 studies
• Mood disorders 17 studies
• Autism 16 studies
• Dementia 14 studies
• Other neuro-degenerative conditions 10 studies
• TBI 7 studies
• Publication of the world’s first set of clinical MEG Clinical
Practice Guidelines (CPGs)
52. The puzzling dichotomy: on-going challenges
• ‘‘Existing disparities in the current practice of clinical MEG in the
United States necessitate clinical practice guidelines” (Bagic,
2011)
• Need to Identify ‘‘a basis to harmonize clinical MEG
procedures” (De Tiège et al., 2017)
• Symposium ‘‘Quo Vadis Clinical MEG Worldwide?” (31st ICCN
in Washington DC May 6, 2018)
53. European clinical centres survey
• 12 clinical European MEG centres included in this study
• 10 (83%) reported to use MEG for pre-surgical functional
mapping (median number of investigations 25, total: 244)
54. On-going operational challenges
1. Unfavourable economics of SQUID-based systems (tariff for
insurance reimbursement in USA up to USD 10.000 per test)
2. Relatively low penetrance to clinical routine
3. Evident lack of standardization in procedures, which limits
large scale studies (meta-analyses) and complicates training of
clinical scientific staff
4. Lack of clinically driven design of user interface and pipelines
of existing systems
5. Reliance of open-source software with no clinical validation
58. Effect of head size on shoulder-crown
distance
Courtesy K.D. Singh
CUBRIC, Cardiff University, UK
59. 5% and 95% confidence intervals, for
children aged 2-12.
The red dotted line indicates the depth of
the Dewar helmet; children with a
shoulder-crown distance below this line
would not be fully inserted into the
helmet.
Green triangles indicate the shoulder-
crown distance of some of our patients
from the BCH Epilepsy Surgery
Programme: children as old as 10+
years fall below the red line.
Mean shoulder-crown distance
61. The total mean distance (left plus right),
with 5 and 95% confidence intervals,
between a child’s temples and the
helmet sides. At age 2, the temporal
lobes are 2-3 cm further from the MEG
sensors than at age 16;
1 cm is equivalent to a 5-fold increase
in SNR
.
Head distance from dewar with age
63. Clinical MEG at Aston in 9 steps
ü Referral and screening form (metal, implantable devices)
ü On arrival, clinician integrates referral with further history
ü Removal of metallic objects
ü Explanation regarding protocols (spontaneous activity, mapping
eloquent cortex, sleep …), offer to view video on screen
ü Data acquisition (high sampling rate)
ü MRI MPRAGE on 3T Siemens Trio for co-registration
ü Review sensor-space data for IEA and spatial filtering data:
analysis by post doctoral staff
ü Team discussion on VE time-series and corresponding sensor
space data
ü Report prepared by Consultant and posted to referring team
64. Localising data in the time domain
1. Statistical or visual identification of
abnormal transients with coherent
topography (IEDs)
2. Single vs. averaged IEDs
3. Localising sources of abnormal activity
76. So far, for the 482 referrals
77/482 (16%) patients did not show any IEAs
Of the 405 who showed abnormalities
307 (75.8%) patients showed at least one source within the
epileptogenic lesion
98 (24.2%) patients have had intraoperative verification
Of these 98 patients
73 (74.5%) had at least one identified source within the
context of the resected area and Engel’s class I outcome
17 (17.4%) had sources concordant at lobar level
8 (8.1%) had sources in a different lobe
77.
78. Final considerations: current
challenges
§ Large datasets vs short epochs: long processing time
§ Historically sensitive to excessive movement: limits use in ictal
recordings.
§ Not feasible at patient’s bedside (limiting for ictal and for
prolonged recordings)
§ Sensitivity to the distance of sources from sensor (helmet
design/ software optimisation for paediatric age)
§ Relatively insensitive to radial sources ? In clinical practice
virtually immaterial
§ High frequency oscillations are powerful biomarkers of epileptic
zone: SNR of current and future technology at 250-500 Hz ?
79. Practical Implications
1. Visual Inspection: will it still be necessary ?
2. Which department does the technique belong to?
3. Training a new generation of HCS
4. Is there a role for high density MEG in signal
space?